Pioglitazone, nuclear receptors, and aerodigestive prevention

Keyphrases

• Nuclear Receptor 100%
• Pioglitazone 100%
• Cancer Prevention 100%
• Aerodigestive 100%
• Type 2 Diabetes Mellitus (T2DM) 50%
• Estrogen 50%
• Antagonism 50%
• Nuclear Receptor Corepressor 50%
• Breast Carcinoma 50%
• High-risk Subjects 50%
• Receptor Targets 50%
• Intense Interests 50%
• Accrual Strategies 50%
• Biomarker Strategy 50%
• Lung Carcinoma 50%
• Widespread Adoption 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Pioglitazone 100%
• Cell Nucleus Receptor 100%
• Malignant Neoplasm 66%
• Receptor Agonist 33%
• Biological Marker 33%
• Peroxisome Proliferator Activated Receptor 33%
• Breast Carcinoma 33%
• Lung Carcinoma 33%
• Non Insulin Dependent Diabetes Mellitus 33%

Medicine and Dentistry

• Pioglitazone 100%
• Cell Nucleus Receptor 100%
• Cancer Prevention 66%
• Biological Marker 33%
• Maturity Onset Diabetes of the Young 33%
• Lung Carcinoma 33%
• Breast Carcinoma 33%
• Peroxisome Proliferator Activated Receptor 33%